Ambrx Biopharma Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Ambrx Biopharma Inc. reported Increase (Decrease) in Prepaid Expense and Other Assets of $705.00 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2023-08-09
- Ambrx Biopharma Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2023-06-30 was $864.00K.
- Ambrx Biopharma Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2023-03-31 was -$159.00K, a 111.71% decline year-over-year.
- Ambrx Biopharma Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2022-06-30 was -$481.00K.
- Ambrx Biopharma Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2022-03-31 was $1.36M.
- Ambrx Biopharma Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $41.00K, a 98.44% decline from fiscal 2021.
- Ambrx Biopharma Inc. increase (decrease) in prepaid expense and other assets for fiscal 2021 was $2.63M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|
| 2023-06-30 | $864.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $705.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | -$159.00K 10-Q · filed 2023-05-11 | ||
| 2022-12-31 | $41.00K 10-K · filed 2023-03-30 | ||
| 2022-06-30 | -$481.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $877.00K 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $1.36M 10-Q · filed 2023-05-11 | ||
| 2021-12-31 | $2.63M 10-K · filed 2023-03-30 | ||
| 2021-06-30 | $2.65M 6-K · filed 2022-08-29 | ||
| 2020-12-31 | $961.00K 20-F · filed 2022-04-26 | ||
| 2019-12-31 | -$1.49M 20-F · filed 2022-04-26 |